Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
02/19/2021 02/22/2021 02/23/2021 02/24/2021 02/25/2021 Date
59.1(c) 58.36(c) 58.02(c) 57.86(c) 58.02 Last
801 121 813 120 1 019 429 769 873 776 133 Volume
-1.34% -1.25% -0.58% -0.28% +0.28% Change
More quotes
Financials (USD)
Sales 2021 21 722 M - -
Net income 2021 1 298 M - -
Net Debt 2021 13 100 M - -
P/E ratio 2021 15,7x
Yield 2021 1,90%
Sales 2022 22 725 M - -
Net income 2022 1 576 M - -
Net Debt 2022 12 139 M - -
P/E ratio 2022 12,9x
Yield 2022 2,14%
Capitalization 20 680 M 20 773 M -
EV / Sales 2021 1,56x
EV / Sales 2022 1,44x
Nbr of Employees 125 364
Free-Float 63,7%
More Financials
Company
Fresenius Medical Care AG & Co. KGaA is the world's leading supplier of services and equipment for patients with kidney problems. Net sales break down by activity as follows: - clinical care services (79.4%): operated, at the end of 2019, 3,994 institutions; - manufacturing of dialyzers and related products (20.6%): hemo-dialysis and pediatric dialysis machines, etc. The group also offers therapies accompanied by... 
More about the company
Notations Surperformance© of Fresenius Medical Care AG & Co. KGaA
Trading Rating : Investor Rating :
More Ratings
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
09:14aFRESENIUS MEDICAL CARE : published form 20-F for the fiscal year 2020
AQ
08:13aFMC FRESENIUS MEDICAL CARE AG & CO K : Independant Research reiterates its Buy r..
MD
04:36aDGAP-DD : Fresenius SE & Co. KGaA english
DJ
03:51aDGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
02/24FRESENIUS SE : NorldLB keeps its Buy rating
MD
02/24FRESENIUS MEDICAL CARE : RBC Adjusts Price Target on Fresenius Medical Care to $..
MT
02/24FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reiterates its Neutral rati..
MD
02/24FRESENIUS SE : UBS reiterates its Neutral rating
MD
02/24FMC FRESENIUS MEDICAL CARE AG & CO K : UBS reaffirms its Buy rating
MD
02/24FRESENIUS SE : Independant Research reaffirms its Buy rating
MD
02/24FRESENIUS SE : Credit Suisse sticks Neutral
MD
02/24PRESS RELEASE : Fresenius Medical Care AG & Co. KGaA published form 20-F for the..
DJ
02/24FRESENIUS MEDICAL CARE : published form 20-F for the fiscal year 2020
EQ
02/23FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 50 of the Wp..
EQ
02/23EUROPE : European shares end lower on tech losses as bond yields weigh
RE
More news
News in other languages on FRESENIUS MEDICAL CARE AG & CO. KGAA
04:36aDGAP-DD : Fresenius SE & Co. KGaA deutsch
03:51aDGAP-DD : Fresenius Medical Care AG & Co. KGaA deutsch
03:51aFresenius Medical Care AG & Co. KGaA
02/24Fresenius Medical Care AG & Co. KGaA veröffentlicht Form 20-F für das Geschäf..
02/24DGAP-NEWS : Fresenius Medical Care AG & Co. KGaA veröffentlicht Form 20-F für da..
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 80,67 $
Last Close Price 70,42 $
Spread / Highest target 45,8%
Spread / Average Target 14,6%
Spread / Lowest Target -25,9%
EPS Revisions
Managers and Directors
NameTitle
Rice Powell Chairman-Management Board
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer